Sagimet Biosciences Inc. (SGMT)

NASDAQ: SGMT · Real-Time Price · USD

6.48

+0.05 (0.78%)

At close: Jun 12, 2026, 4:00 PM EDT

6.49

+0.01 (0.14%)

Pre-market: Jun 15, 2026, 8:45 AM EDT

Sagimet Biosciences Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	36.63	35.02	75.84	75.14	0.16	56.73
Short-Term Investments	67.91	78.1	75.41	19.76	32.19	-
Cash & Short-Term Investments	104.54	113.12	151.25	94.9	32.35	56.73
Cash Growth	-27.69%	-25.21%	59.38%	193.39%	-42.98%	-28.11%
Other Current Assets	3.18	3.28	1.52	1.75	0.45	1.93
Total Current Assets	107.72	116.4	152.77	96.65	32.79	58.66
Net Property, Plant & Equipment	0.04	0.08	0.08	0.07	0.21	0.34
Long-Term Investments	-	-	7.41	-	-	-
Other Long-Term Assets	-	-	-	-	0.03	0.03
Total Assets	107.76	116.48	160.26	96.72	33.03	59.03
Accounts Payable	2.3	1.31	1.43	0.19	1.13	0.76
Accrued Expenses	2.96	3.71	2.95	5.4	4.02	1.56
Current Portion of Leases	0.04	0.08	0.08	0.07	0.13	0.12
Total Current Liabilities	5.3	5.1	4.45	5.65	5.28	2.44
Long-Term Leases	-	-	-	-	0.08	0.22
Other Long-Term Liabilities	-	-	-	-	0	0.01
Total Long-Term Liabilities	-	-	-	-	0.08	0.23
Total Liabilities	5.3	5.1	4.45	5.65	5.36	2.67
Common Stock	0	0	0	0	0	0
Additional Paid-in Capital	459.45	457.61	450.88	340.78	35	33.11
Accumulated Other Comprehensive Income	0.01	0.12	0.23	0.03	-0.08	-
Retained Earnings	-357	-346.35	-295.31	-249.74	-221.87	-191.37
Total Common Shareholders' Equity	102.46	111.38	155.81	91.07	-186.95	-158.26
Minority Interest	-	-	-	-	214.62	214.62
Shareholders' Equity	102.46	111.38	155.81	91.07	27.67	56.36
Total Liabilities & Equity	107.76	116.48	160.26	96.72	33.03	59.03
Total Debt	0.04	0.08	0.08	0.07	0.21	0.35
Net Cash (Debt)	104.5	113.05	151.17	94.83	32.13	56.38
Net Cash Growth	-7.56%	-25.22%	59.41%	195.11%	-43.01%	-28.05%
Net Cash Per Share	3.22	3.50	4.82	9.07	174.06	305.40
Book Value	102.46	111.38	155.81	91.07	-186.95	-158.26
Book Value Per Share	3.16	3.44	4.97	8.71	-1012.63	-857.22
Tangible Book Value	102.46	111.38	155.81	91.07	-186.95	-158.26
Tangible Book Value Per Share	3.16	3.44	4.97	8.71	-1012.63	-857.22

SEC Filings: 10-K · 10-Q